Medmira Stock Performance
| MIR Stock | CAD 0.08 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0326, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MedMira's returns are expected to increase less than the market. However, during the bear market, the loss of holding MedMira is expected to be smaller as well. At this point, MedMira has a negative expected return of -0.0493%. Please make sure to verify MedMira's information ratio, as well as the relationship between the potential upside and day median price , to decide if MedMira performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MedMira has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, MedMira is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
1 | MedMira Boosts Leadership for North American Growth - TipRanks | 10/03/2024 |
| Begin Period Cash Flow | 33.5 K |
MedMira |
MedMira Relative Risk vs. Return Landscape
If you would invest 9.00 in MedMira on August 28, 2024 and sell it today you would lose (1.00) from holding MedMira or give up 11.11% of portfolio value over 90 days. MedMira is currently producing negative expected returns and takes up 5.349% volatility of returns over 90 trading days. Put another way, 47% of traded stocks are less volatile than MedMira, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
MedMira Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedMira's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MedMira, and traders can use it to determine the average amount a MedMira's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0092
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MIR |
Estimated Market Risk
| 5.35 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MedMira is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MedMira by adding MedMira to a well-diversified portfolio.
MedMira Fundamentals Growth
MedMira Stock prices reflect investors' perceptions of the future prospects and financial health of MedMira, and MedMira fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MedMira Stock performance.
| Return On Asset | -0.26 | ||||
| Operating Margin | (7.40) % | ||||
| Current Valuation | 58.57 M | ||||
| Shares Outstanding | 701.73 M | ||||
| Price To Earning | (5.00) X | ||||
| Price To Sales | 146.45 X | ||||
| Revenue | 432.53 K | ||||
| Gross Profit | (512.51 K) | ||||
| EBITDA | (1.58 M) | ||||
| Net Income | (2.68 M) | ||||
| Cash And Equivalents | 1.06 K | ||||
| Total Debt | 9.27 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (1.27 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 56.14 M | ||||
| Total Asset | 3.65 M | ||||
| Retained Earnings | (97.96 M) | ||||
| Working Capital | (14.03 M) | ||||
About MedMira Performance
Evaluating MedMira's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if MedMira has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MedMira has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 88.27 | 83.86 | |
| Return On Tangible Assets | (0.66) | (0.69) | |
| Return On Capital Employed | 0.14 | 0.13 | |
| Return On Assets | (0.66) | (0.69) | |
| Return On Equity | 0.20 | 0.19 |
Things to note about MedMira performance evaluation
Checking the ongoing alerts about MedMira for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MedMira help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MedMira generated a negative expected return over the last 90 days | |
| MedMira has high historical volatility and very poor performance | |
| MedMira has some characteristics of a very speculative penny stock | |
| MedMira has a very high chance of going through financial distress in the upcoming years | |
| MedMira has accumulated 9.27 M in total debt. MedMira has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MedMira until it has trouble settling it off, either with new capital or with free cash flow. So, MedMira's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedMira sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedMira to invest in growth at high rates of return. When we think about MedMira's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 432.53 K. Net Loss for the year was (2.68 M) with loss before overhead, payroll, taxes, and interest of (512.51 K). | |
| MedMira has accumulated about 1.06 K in cash with (1.27 M) of positive cash flow from operations. | |
| Roughly 69.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing MedMira's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MedMira's stock is overvalued or undervalued compared to its peers.
- Examining MedMira's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MedMira's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MedMira's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MedMira's stock. These opinions can provide insight into MedMira's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.